Hyperthermic intraperitoneal chemotherapy (secondary cytoreduction CRS + HIPEC) for recurrent epithelial ovarian cancer (EOC): Indian experience. This is an ASCO Meeting Abstract from the 2015 ASCO ...
Ten-year relative suvival for ovarian cancer. Background: When GOG 172 showed a benefit to intraperitoneal (IP) chemotherapy as frontline treatment for advanced ovarian cancer, our division adopted IP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results